TG Therapeutics Announces Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis
Gilead and Galapagos Announce Tortuga Phase 2 Study of Filgotinib in Ankylosing Spondylitis Achieves Primary Endpoint
pharmaceutical investing BioCryst Announces Publication of APeX-1 Clinical Trial Results for BCX7353 in The New England Journal of Medicine
Brixton Metals Drills 14.75m of 1.25% Copper, 1.71 g/t Gold, 149.0 g/t Silver at the Near Surface Glenfiddich Zone, Camp Creek Corridor
CoTec Files Preliminary Economic Assessment and Technical Report for the Lac Jeannine Mine Tailings Reclamation and Restoration Project, Québec, Canada
Stallion Uranium Intersects Elevated Radioactivity and Alteration at Coyote; Continues Expanded Drill Program, Mobilizes Geophysical Survey
